Eversept Partners, Lp Top Holdings and 13F Report (2026)

About Eversept Partners, Lp

Investment Activity

Eversept Partners, Lp has $1.90 billion in total holdings as of March 31, 2026.
Eversept Partners, Lp owns shares of 117 different stocks, but just 32 companies or ETFs make up 80% of its holdings.
Approximately 31.12% of the portfolio was purchased this quarter.
About 31.41% of the portfolio was sold this quarter.
This quarter, Eversept Partners, Lp has purchased 107 new stocks and bought additional shares in 37 stocks.
Eversept Partners, Lp sold shares of 37 stocks and completely divested from 30 stocks this quarter.

Largest Holdings

United Therapeutics: $156,707,418
Invesco QQQ: $137,772,866
ABIVAX SA: $104,048,001
GSK: $98,523,808
Vera Therapeutics: $87,431,296

Largest New Holdings this Quarter

N72482156 - QIAGEN NV: $40,906,065 Holding
92532F100 - Vertex Pharmaceuticals: $40,188,600 Holding
95040Q104 - Welltower: $35,776,218 Holding
42250P103 - HEALTHPEAK PROPERTIES INC: $32,548,980 Holding
681936100 - Omega Healthcare Investors: $25,664,498 Holding

Largest Purchases this Quarter

Brookdale Senior Living: 3,193,626 shares (about $43.69M)
QIAGEN NV: 1,021,630 shares (about $40.91M)
SPDR S&P 500 ETF Trust: 62,100 shares (about $40.39M)
Vertex Pharmaceuticals: 90,000 shares (about $40.19M)
Welltower: 180,953 shares (about $35.78M)

Largest Sales this Quarter

GSK: 894,546 shares (about $49.37M)
Vera Therapeutics: 899,018 shares (about $36.17M)
Bruker: 666,776 shares (about $24.08M)
Viridian Therapeutics: 1,068,966 shares (about $20.91M)
Travere Therapeutics: 632,358 shares (about $18.79M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
UTHR United Therapeutics	$156,707,418	$6,925,413 â–²	4.6%	264,271	8.3%	Medical
QQQ Invesco QQQ	$137,772,866	$7,907,366 â–²	6.1%	238,700	7.3%	Finance
ABIVAX SA	$104,048,001	$30,798,185 â–²	42.0%	934,423	5.5%	SPONSORED ADS
GSK GSK	$98,523,808	$49,369,994 â–¼	-33.4%	1,785,175	5.2%	Medical
VERA Vera Therapeutics	$87,431,296	$36,167,494 â–¼	-29.3%	2,173,286	4.6%	Medical
NTRA Natera	$76,938,753	$10,043,498 â–²	15.0%	384,713	4.1%	Medical
SPY SPDR S&P 500 ETF Trust	$69,586,380	$40,386,114 â–²	138.3%	107,000	3.7%	Finance
SNDX Syndax Pharmaceuticals	$67,408,130	$10,016,441 â–¼	-12.9%	2,885,622	3.6%	Medical
CLDX Celldex Therapeutics	$56,715,868	$11,206,391 â–²	24.6%	1,788,016	3.0%	Medical
PCVX Vaxcyte	$53,704,855	$15,894,770 â–¼	-22.8%	924,193	2.8%	Medical
BKD Brookdale Senior Living	$48,817,832	$43,688,803 â–²	851.8%	3,568,555	2.6%	Medical
IONS Ionis Pharmaceuticals	$47,464,389	$7,049,599 â–²	17.4%	632,100	2.5%	Medical
QIAGEN NV	$40,906,065	$40,906,065 â–²	New Holding	1,021,630	2.2%	ORD SHARES
VRTX Vertex Pharmaceuticals	$40,188,600	$40,188,600 â–²	New Holding	90,000	2.1%	Medical
HCA HCA Healthcare	$37,494,332	$7,877,080 â–¼	-17.4%	79,229	2.0%	Medical
TLT iShares 20+ Year Treasury Bond ETF	$37,172,672	$17,233,972 â–²	86.4%	428,800	2.0%	ETF
WELL Welltower	$35,776,218	$35,776,218 â–²	New Holding	180,953	1.9%	Finance
HEALTHPEAK PROPERTIES INC	$32,548,980	$32,548,980 â–²	New Holding	1,981,070	1.7%	COM
PODD Insulet	$30,121,693	$14,444,966 â–²	92.1%	143,546	1.6%	Medical
BCRX BioCryst Pharmaceuticals	$28,939,086	$446,726 â–²	1.6%	3,039,820	1.5%	Medical
GERN Geron	$28,063,976	$1,750,601 â–²	6.7%	18,834,883	1.5%	Medical
OHI Omega Healthcare Investors	$25,664,498	$25,664,498 â–²	New Holding	585,680	1.4%	Finance
LQDA Liquidia	$25,564,774	$6,338,395 â–²	33.0%	677,392	1.3%	Medical
CYH Community Health Systems	$25,511,206	$2,156,428 â–²	9.2%	8,677,281	1.3%	Medical
AVTR Avantor	$23,318,410	$1,586,479 â–¼	-6.4%	2,974,287	1.2%	Medical
EHC Encompass Health	$18,775,680	$8,432,728 â–²	81.5%	194,104	1.0%	Medical
LLY Eli Lilly and Company	$17,475,630	$7,704,913 â–²	78.9%	19,000	0.9%	Medical
TVTX Travere Therapeutics	$16,120,943	$18,787,356 â–¼	-53.8%	542,610	0.9%	Medical
INSM Insmed	$15,370,880	$15,370,880 â–²	New Holding	94,000	0.8%	Medical
CTMX CytomX Therapeutics	$14,986,016	$3,202,693 â–²	27.2%	3,188,514	0.8%	Medical
HYG iShares iBoxx $ High Yield Corporate Bond ETF	$14,320,800	$14,320,800 â–²	New Holding	180,000	0.8%	ETF
RGEN Repligen	$14,230,889	$14,230,889 â–²	New Holding	120,785	0.8%	Medical
BETA BIONICS INC	$14,176,677	$7,380,492 â–²	108.6%	1,414,838	0.7%	COM
VRDN Viridian Therapeutics	$13,951,542	$20,908,975 â–¼	-60.0%	713,269	0.7%	Medical
ARQT Arcutis Biotherapeutics	$13,584,225	$3,344,248 â–²	32.7%	576,580	0.7%	Medical
ARDX Ardelyx	$13,354,382	$3,080,759 â–²	30.0%	2,229,446	0.7%	Medical
LTC LTC Properties	$11,930,069	$11,930,069 â–²	New Holding	321,046	0.6%	Finance
BMRN BioMarin Pharmaceutical	$11,736,814	$6,440,990 â–²	121.6%	207,768	0.6%	Medical
CHE Chemed	$11,731,471	$11,731,471 â–²	New Holding	31,057	0.6%	Medical
PHVS Pharvaris	$11,496,620	$910,130 â–¼	-7.3%	406,960	0.6%	Medical
UNH UnitedHealth Group	$10,823,600	$5,645,049 â–¼	-34.3%	40,000	0.6%	Medical
IWM iShares Russell 2000 ETF	$9,920,000	$9,920,000 â–²	New Holding	40,000	0.5%	Finance
PNTG The Pennant Group	$9,515,185	$555,285 â–²	6.2%	312,178	0.5%	Medical
XLK Technology Select Sector SPDR Fund	$9,303,000	$9,303,000 â–²	New Holding	70,000	0.5%	ETF
NAMS NewAmsterdam Pharma	$9,147,306	$4,323,367 â–¼	-32.1%	285,764	0.5%	Medical
PALISADE BIO INC	$8,728,123	$707,086 â–¼	-7.5%	4,987,499	0.5%	COM
MRNA Moderna	$8,113,166	$5,492,242 â–¼	-40.4%	159,708	0.4%	Medical
VKTX Viking Therapeutics	$7,780,639	$7,780,639 â–²	New Holding	239,110	0.4%	Medical
ICLR Icon	$7,601,014	$3,003,755 â–¼	-28.3%	68,688	0.4%	Medical
XENE Xenon Pharmaceuticals	$7,534,728	$5,920,019 â–¼	-44.0%	129,574	0.4%	Medical
RVTY Revvity	$7,434,059	$6,826,834 â–¼	-47.9%	84,854	0.4%	Medical
AGIO Agios Pharmaceuticals	$6,766,000	$6,766,000 â–²	New Holding	200,000	0.4%	Medical
GPCR Structure Therapeutics	$6,653,335	$504,895 â–²	8.2%	138,036	0.4%	Medical
TECH Bio-Techne	$6,579,325	$13,143,860 â–¼	-66.6%	125,896	0.3%	Medical
GKOS Glaukos	$6,482,639	$9,394,088 â–¼	-59.2%	60,214	0.3%	Medical
THC Tenet Healthcare	$5,569,210	$5,569,210 â–²	New Holding	29,512	0.3%	Medical
MDGL Madrigal Pharmaceuticals	$5,234,700	$5,234,700 â–²	New Holding	10,000	0.3%	Medical
ISRG Intuitive Surgical	$5,125,748	$3,200,654 â–¼	-38.4%	11,119	0.3%	Medical
PRAXIS PRECISION MEDICINES I	$4,768,412	$4,768,412 â–²	New Holding	14,800	0.3%	COM NEW
ESPR Esperion Therapeutics	$4,756,539	$5,795,566 â–¼	-54.9%	1,735,963	0.3%	Medical
MOH Molina Healthcare	$4,373,706	$1,687,445 â–¼	-27.8%	32,811	0.2%	Medical
HQY HealthEquity	$4,313,382	$11,208,826 â–¼	-72.2%	51,614	0.2%	Medical
BRKR Bruker	$4,226,510	$24,083,952 â–¼	-85.1%	117,013	0.2%	Computer and Technology
DAWN Day One Biopharmaceuticals	$3,942,859	$3,942,859 â–²	New Holding	183,902	0.2%	Medical
XBI SPDR S&P Biotech ETF	$3,831,900	$8,864,462 â–¼	-69.8%	30,000	0.2%	ETF
CMPS Compass Pathways	$3,748,920	$3,748,920 â–²	New Holding	677,924	0.2%	Medical
CNC Centene	$3,655,486	$6,955,285 â–¼	-65.5%	111,652	0.2%	Medical
GRACE THERAPEUTICS INC	$3,503,058	$3,503,058 â–²	New Holding	756,600	0.2%	COM
ENGENE HOLDINGS INC	$3,476,798	$372,561 â–²	12.0%	510,543	0.2%	COM
UHS Universal Health Services	$3,257,254	$3,257,254 â–²	New Holding	18,200	0.2%	Medical
EHAB Enhabit	$3,204,785	$125,979 â–²	4.1%	227,451	0.2%	Medical
XLE Energy Select Sector SPDR Fund	$3,063,000	$3,063,000 â–²	New Holding	50,000	0.2%	ETF
DEFINIUM THERAPEUTICS INC	$3,037,665	$3,037,665 â–²	New Holding	160,723	0.2%	COM SHS
EQ Equillium	$2,997,986	$2,997,986 â–²	New Holding	1,498,993	0.2%	Medical
ENSG The Ensign Group	$2,974,342	$2,974,342 â–²	New Holding	14,761	0.2%	Medical
REPL Replimune Group	$2,959,487	$2,959,487 â–²	New Holding	386,861	0.2%	Medical
IVVD Invivyd	$2,959,254	$177,085 â–²	6.4%	2,276,349	0.2%	Medical
PMVP PMV Pharmaceuticals	$2,911,966	$2,911,966 â–²	New Holding	2,348,360	0.2%	Medical
ALEC Alector	$2,904,878	$741,627 â–²	34.3%	1,351,106	0.2%	Medical
ALTO NEUROSCIENCE INC	$2,813,777	$2,813,777 â–²	New Holding	125,168	0.1%	COM SHS
RLAY Relay Therapeutics	$2,693,515	$2,173,399 â–¼	-44.7%	270,705	0.1%	Medical
LB PHARMACEUTICALS INC	$2,470,883	$2,470,883 â–²	New Holding	100,198	0.1%	COM SHS
LPCN Lipocine	$2,356,962	$2,356,962 â–²	New Holding	294,989	0.1%	Medical
VIR Vir Biotechnology	$2,240,000	$2,240,000 â–²	New Holding	250,000	0.1%	Medical
ANTERIS TECHNOLOGIES GLOBAL	$2,226,588	$548,412 â–¼	-19.8%	401,187	0.1%	COM
AMARIN CORP PLC	$2,135,959	$353,880 â–¼	-14.2%	147,715	0.1%	SPONSORED ADR
SVRA Savara	$2,098,081	$1,168,816 â–²	125.8%	384,264	0.1%	Medical
RLMD Relmada Therapeutics	$1,934,177	$1,934,177 â–²	New Holding	277,899	0.1%	Medical
CONTINEUM THERAPEUTICS INC	$1,912,128	$116,469 â–²	6.5%	146,411	0.1%	CL A
SUTRO BIOPHARMA INC	$1,822,441	$2,999,414 â–¼	-62.2%	73,161	0.1%	COM SHS
INOVIO PHARMACEUTICALS INC	$1,801,526	$1,801,526 â–²	New Holding	1,035,360	0.1%	COM SHS
SURROZEN INC	$1,707,717	$1,067,964 â–¼	-38.5%	58,624	0.1%	COM NEW
KARYOPHARM THERAPEUTICS INC	$1,670,855	$1,670,855 â–²	New Holding	299,974	0.1%	COM NEW
IFRX InflaRx	$1,572,868	$1,128 â–²	0.1%	1,758,573	0.1%	Medical
ANAB AnaptysBio	$1,502,356	$5,204,256 â–¼	-77.6%	27,089	0.1%	Medical
NVCR NovoCure	$1,470,595	$151,935 â–²	11.5%	134,917	0.1%	Medical
BIOVENTUS INC	$1,452,674	$2,849,902 â–¼	-66.2%	159,110	0.1%	COM CL A
AGILON HEALTH INC	$1,396,811	$1,396,811 â–²	New Holding	176,588	0.1%	COM NEW
RARE Ultragenyx Pharmaceutical	$1,310,946	$5,334,016 â–¼	-80.3%	62,575	0.1%	Medical
EVOMMUNE INC	$1,257,093	$1,257,093 â–²	New Holding	54,680	0.1%	COM SHS

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Eversept Partners, Lp Top Holdings and 13F Report (2026)

About Eversept Partners, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Eversept Partners, Lp Top Holdings and 13F Report (2026)

About Eversept Partners, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofEversept Partners, Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools